Patent ID: 9315575
Filing Date: 2016-04-19
CPC Classification: A61K,A61P,C07K,Y10S

Claim Text:
1. A method of treatment of a disease or disorder selected from the group consisting of asthma, atopic dermatitis, allergic rhinitis, fibrosis and Hodgkin's lymphoma, the method comprising administering a specific binding member to a patient with the disease or disorder, wherein the specific binding member binds interleukin-13 (IL-13) and comprises an antibody antigen-binding site which is composed of a human antibody heavy chain variable region (VH) and a human antibody light chain variable region (VL) comprising a set of complementarity determining regions (CDRs) HCDR1, HCDR2, HCDR3, LCDR1, LCDR2 and LCDR3, wherein the VH comprises HCDR1, HCDR2 and HCDR3 and the VL comprises LCDR1, LCDR2 and LCDR3, wherein: HCDR1 comprises SEQ ID NO:7; HCDR2 comprises SEQ ID NO:8; HCDR3 comprises SEQ ID NO:9; LCDR1 comprises SEQ ID NO:10; LCDR2 comprises SEQ ID NO:11; and LCDR3 comprises SEQ ID NO:12.